Dr. Reddy’s Laboratories has reappointed GV Prasad as Co-Chairman and Managing Director for another five-year term starting January 30, 2026. The decision, approved by the company’s Board of Directors and Nomination & Remuneration Committee, reaffirms Dr. Reddy’s commitment to strategic continuity and transformative leadership.
Under Prasad’s stewardship, the company has significantly expanded its global pharmaceutical footprint, championed innovation, and led ethical governance and digital transformation initiatives. His renewed leadership is seen as pivotal to sustaining the organization’s growth and mission-driven approach to healthcare.
Beyond business leadership, Prasad is recognized for advancing sustainability, promoting patient-centric healthcare models, and mentoring future leaders. He actively contributes to academic and leadership institutions, serving on boards such as the Indian School of Business, the International Foundation for Research and Education, and McKinsey’s Centre for CEO Excellence. With a background in chemical engineering and industrial administration, Prasad continues to bring a unique blend of scientific insight and business acumen to Dr. Reddy’s evolution.